Aurélie Courtin

SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth.

Stéphanie Filleur, Aurélie Courtin, Slimane Ait‐Si‐Ali et al. · PubMed · 2003 · 254 citations

Medicine, Cancer Biology, Oncology +17

Estetrol is a weak estrogen antagonizing estradiol-dependent mammary gland proliferation

Catherine Gérard, Silvia Blacher, Laudine Communal et al. · Journal of Endocrinology · 2014 · 70 citations · Full text

Medicine, Endocrinology, Pharmacology +10

Death receptor pathways mediate targeted and non-targeted effects of ionizing radiations in breast cancer cells

Audrey Luce, Aurélie Courtin, Céline Levalois et al. · Carcinogenesis · 2009 · 69 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Fragment-Based Discovery of a Potent, Orally Bioavailable Inhibitor That Modulates the Phosphorylation and Catalytic Activity of ERK1/2

Tom D. Heightman, Valério Berdini, Hannah Braithwaite et al. · Journal of Medicinal Chemistry · 2018 · 66 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +16

CHK1 Inhibition Synergizes with Gemcitabine Initially by Destabilizing the DNA Replication Apparatus

Siang‐Boon Koh, Aurélie Courtin, Richard J. Boyce et al. · Cancer Research · 2015 · 62 citations · Full text

Life Sciences, Oncology, Pharmacology +17